Definitions
Sorry, no definitions found. Check out and contribute to the discussion of this word!
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word veno-occlusive.
Examples
-
Some can lead to a dangerous form of fatty infiltration of the liver, some to blockage of the veins inside the liver this is called veno-occlusive disease, and some even to chronic hepatitis and cirrhosis.
DR. SANJIV CHOPRA’S LIVER BOOK Sanjiv Chopra 2001
-
Research and development expenses were primarily for the development of Defibrotide to treat and prevent veno-occlusive disease VOD.
unknown title 2011
-
Defibrotide has the potential to become the first drug approved for the prevention and treatment of hepatic veno-occlusive disease (VOD) a serious and potentially fatal complication of hematopoietic stem-cell transplantation (HSCT).
-
Defibrotide will also be featured in a satellite symposium entitled, "Defibrotide for the prevention and treatment of hepatic veno-occlusive disease following stem cell transplantation," on Sunday March 21 from 9: 00 AM?
-
There are wide interindividual differences in BU pharmacokinetics, which increase the risk of veno-occlusive disease, graft rejection and disease relapse.
Naturejobs - All Jobs M Ansari 2010
-
- Utility in prevention of hepatic veno-occlusive children - New insights into biological mechanism of action - Subject of satellite symposium with key opinion leaders VILLA GUARDIA,
WN.com - Articles related to Parents puff gives children asthma, doctors warn 2010
-
There are wide interindividual differences in BU pharmacokinetics, which increase the risk of veno-occlusive disease, graft rejection and disease relapse.
Naturejobs - All Jobs M Ansari 2010
-
Defibrotide will also be featured in a satellite symposium entitled, "Defibrotide for the prevention and treatment of hepatic veno-occlusive disease following stem cell transplantation," on Sunday March 21 from 9: 00 AM - 10: 30 AM local time in the Austria Center,
-
(EMAILWIRE. COM, April 05, 2010) San Antonio, TX - Gentium S.p. A. (ADR) (Public, NASDAQ: GENT), is up 55% on Friday, is a biopharmaceutical company focused on the development and manufacture of defibrotide, a deoxyribonucleic acid (DNA) based drug derived from pig intestines, to treat and prevent a disease called hepatic veno-occlusive disease
-
Furthermore, 5.7% of patients in the Mylotarg plus chemotherapy arm died during treatment, compared to 1.4% on chemotherapy alone, and the FDA noted that at initial approval, Mylotarg was associated with a serious liver condition called veno-occlusive disease, which can be fatal; "this rate has increased in the postmarket setting," the agency added.
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.